Literature DB >> 35814891

Dupilumab-associated ulcerative keratitis.

Matthew M Wilson1, Philipp K Roberts1,2, Mark Daniell1,3,4.   

Abstract

Entities:  

Year:  2022        PMID： 35814891      PMCID： PMC9203468          DOI： 10.18240/ijo.2022.06.23

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.645


× No keyword cloud information.
  11 in total

1.  Pathomechanism of dupilumab-associated inflammatory eye symptoms.

Authors:  J Wohlrab; T Werfel; A Wollenberg
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-07-03       Impact factor: 6.166

2.  Cicatrizing Blepharoconjunctivitis Occurring During Dupilumab Treatment and a Proposed Algorithm for Its Management.

Authors:  Russell M Levine; Ian W Tattersall; Paul A Gaudio; Brett A King
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

3.  Punctal stenosis associated with dupilumab therapy for atopic dermatitis.

Authors:  Debora H Lee; Liza M Cohen; Michael K Yoon; Jeremiah P Tao
Journal:  J Dermatolog Treat       Date:  2020-01-07       Impact factor: 3.359

Review 4.  Review of Atopic Dermatitis and Topical Therapies.

Authors:  Julia N Mayba; Melinda J Gooderham
Journal:  J Cutan Med Surg       Date:  2016-12-27       Impact factor: 2.092

Review 5.  Diagnosis and Management of Conjunctivitis for the Dermatologist.

Authors:  Melinda Gooderham; Julian McDonald; Kim Papp
Journal:  J Cutan Med Surg       Date:  2017-12-01       Impact factor: 2.092

Review 6.  Dupilumab: A review of its use in the treatment of atopic dermatitis.

Authors:  Melinda J Gooderham; H Chih-Ho Hong; Panteha Eshtiaghi; Kim A Papp
Journal:  J Am Acad Dermatol       Date:  2018-03       Impact factor: 11.527

Review 7.  Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis.

Authors:  Fa-Ping Wang; Xiao-Ju Tang; Chuan-Qi Wei; Lin-Rui Xu; Hui Mao; Feng-Ming Luo
Journal:  J Dermatol Sci       Date:  2018-02-20       Impact factor: 4.563

8.  Conjunctivitis in dupilumab clinical trials.

Authors:  B Akinlade; E Guttman-Yassky; M de Bruin-Weller; E L Simpson; A Blauvelt; M J Cork; E Prens; P Asbell; E Akpek; J Corren; C Bachert; I Hirano; J Weyne; A Korotzer; Z Chen; T Hultsch; X Zhu; J D Davis; L Mannent; J D Hamilton; A Teper; H Staudinger; E Rizova; G Pirozzi; N M H Graham; B Shumel; M Ardeleanu; A Wollenberg
Journal:  Br J Dermatol       Date:  2019-05-07       Impact factor: 9.302

9.  Corneal ulceration associated with dupilumab use in a patient with atopic dermatitis.

Authors:  Gavin Li; Meghan Berkenstock; Uri Soiberman
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-05

10.  Ocular surface disorders associated with the use of dupilumab based on WHO VigiBase.

Authors:  Sunny Park; Jung Hyun Lee; Ji Hyun Park; So Hyang Park; Song Yi Park; Yong Woo Jung; Soo An Choi
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.